Cardiogenic Shock
Acute coronary syndrome guideline includes updates on blood thinners, circulatory support
The American College of Cardiology and American Heart Association issued updated practice guidelines for the management of patients with acute coronary syndrome.
Heart pumps’ indication expanded to pediatric patients with HF, cardiogenic shock
Johnson & Johnson MedTech announced the FDA has approved an expanded indication and granted premarket approval for its heart pumps to be used to treat pediatric patients with symptomatic acute decompensated HF and cardiogenic shock.
SCAI consensus statement offers technical guidance for PCI in patients with STEMI
The Society for Cardiovascular Angiography and Interventions has released a consensus statement on how catheterization laboratories should manage the technical aspects of PCI for patients with STEMI.
Q&A: New class of total artificial heart implanted successfully for first time
The first implantation of a new class of total artificial heart, a rotary pump with a single moving part, was successfully completed by a team at The Texas Heart Institute, the institution reported.
Stand-alone chest pain units may improve STEMI care in poor, densely populated areas
ATLANTA — A system of standalone chest pain units set up in Karachi, Pakistan was associated with good metrics and outcomes for patients with STEMI who could not easily get to a hospital.
Routine use of Impella CP for STEMI-related cardiogenic shock confers survival benefit
ATLANTA — In the DanGer-Shock trial, routine use of a microaxial flow pump, on top of standard care, led to a lower risk for death compared with standard care only for treatment of patients with STEMI and cardiogenic shock.
FDA designates recall of left-sided blood pumps as class I
Abiomed has issued a recall of the instructions for use for its left-sided blood pumps, as the pump catheter may perforate the wall of the left ventricle or cause free wall rupture, hypertension, lack of blood flow or death.
Cardiogenic shock doubles in-hospital mortality risk for children with worsening HF
Data show about one in four children admitted with acute decompensated HF develops cardiogenic shock with 24 hours, with high risk for in-hospital mortality that increases with escalating cardiogenic shock stage.
Urgent ECMO after cardiogenic shock admission could lower mortality
Delayed extracorporeal membrane oxygenation after hospital admission with cardiogenic shock was associated with increased in-hospital mortality, even among less acutely ill patients, researchers reported.
Extracorporeal life support does not reduce death risk in acute MI, cardiogenic shock
In patients with acute MI complicated by cardiogenic shock, use of early extracorporeal life support did not reduce risk for death at 30 days compared with medical therapy alone, researchers reported.